(Q39266966)

10 September 2017

title

Alendronate-associated femoral insufficiency fractures and femoral stress reactions (English)

1 reference

10 September 2017

1 reference

Kemble Wang

1

1 reference

10 September 2017

Afshin Moaveni

series ordinal

2

1 reference

10 September 2017

Adam Dowrick

series ordinal

3

1 reference

10 September 2017

Susan Liew

series ordinal

4

1 reference

10 September 2017

publication date

1 April 2011

1 reference

Journal of Orthopaedic Surgery

10 September 2017

published in

1 reference

10 September 2017

volume

19

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

89-92

1 reference

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F230949901101900121

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F230949901101900121

Severely suppressed bone turnover: a potential complication of alendronate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F230949901101900121

Spontaneous femoral shaft fracture after long-term alendronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F230949901101900121

Severely suppressed bone turnover and atypical skeletal fragility

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F230949901101900121

Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F230949901101900121

An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F230949901101900121

Low-energy femoral shaft fractures associated with alendronate use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F230949901101900121

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F230949901101900121

Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F230949901101900121

10.1177/230949901101900121

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference